Holdings/Diversificado
OPGM3 — GAMA PARTICIPAÇÕES S.A.
CNPJ 02.796.775/0001-40 · listed classes: OPGM3 · CVM code 17965
At a glance
Sixteen years in four lines. A hollow point carries a caveat; a gap is a year without the figure — we never draw a line across a hole. The exact numbers are in the table below.
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE ⟶ | 8.0%! | 8.4%! | 19.2%! | 20.0%! | 23.6%! | 24.9%! | 19.0%! | 3.8%! | -6.3%! | -6.0%! | -8.5%! | -7.9%! | -1.6%! | 0.2%! | -3.9%! | -2.4%! |
| ROIC ⟶ | -4.0%! | -3.8% | — | — | — | — | — | — | -999.9%! | -160.7%! | -132.0%! | -164.7%! | -265.9%! | -430.5%! | -264.0%! | -232.6%! |
| ROA ⟶ | 6.9%! | 7.4% | 10.7% | 4.3% | 5.9% | 7.1% | 9.1% | 3.6% | -5.9% | -5.6% | -7.7% | -7.2% | -1.5% | 0.2% | -3.9% | -2.4%! |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth (1y) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth (5y CAGR) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net debt/EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current ratio ⟶ | 12.25x | 14.59x | 1.23x | 1.29x | 1.35x | 1.42x | 16.35x | 23.72x | 1,332.00x | — | — | — | 1,047.00x | 1,049.00x | 1,009.00x | 985.00x! |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1! | 0.0 | -0.0 | — | — | — | 2024-05-09 |
| 2024T2! | 0.0 | -0.0 | — | — | — | 2024-08-12 |
| 2024T3! | 0.0 | 0.0 | — | — | — | 2025-01-09 |
| 2025T1! | 0.0 | -0.0 | — | — | — | 2025-05-15 |
| 2025T2! | 0.0 | -0.0 | — | — | — | 2025-08-12 |
| 2025T3! | 0.0 | 0.0 | — | — | — | 2025-11-13 |
| 2026T1! | 0.0 | -0.0 | — | — | — | 2026-05-15 |
| 2026T2! | 0.0 | -0.0 | — | — | — | 2026-08-06 |
Full series, every quarter: GET /empresas/OPGM3/trimestres
Dividends per year
No dividends recorded. Note this can mean two different things — the company pays none, or we could not confirm. sem_proventos
Piotroski F-Score 2/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2010 | BPA 1.01.01 | 0.0 | 4.9 |
| 2010 | BPA 1.01.02 | 4.9 | 0.0 |
| 2012 | DMPL 5.06 | -0.7 | 0.0 |
| 2012 | DMPL 5.07 | 0.9 | 1.6 |
This company appears in
Compare
Side by side, with each figure's caveat and how often each company restated its filings.
OPGM3 × GGPS3 · OPGM3 × OSXB3 · OPGM3 × SCAR3 · OPGM3 × DEXP3 · OPGM3 × CSUD3 · OPGM3 × PEAB3
Other companies in Holdings/Diversified
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/OPGM3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 0 sessions · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-09 12:58 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.